Literature DB >> 31215136

Should blood pressure ≥130/80 mm Hg be considered as a cardiovascular disease?

Marijana Tadic1, Cesare Cuspidi2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31215136      PMCID： PMC8030436          DOI： 10.1111/jch.13607

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  22 in total

1.  Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Paul Muntner; Alvaro Alonso; Marcio S Bittencourt; Clifton W Callaway; April P Carson; Alanna M Chamberlain; Alexander R Chang; Susan Cheng; Sandeep R Das; Francesca N Delling; Luc Djousse; Mitchell S V Elkind; Jane F Ferguson; Myriam Fornage; Lori Chaffin Jordan; Sadiya S Khan; Brett M Kissela; Kristen L Knutson; Tak W Kwan; Daniel T Lackland; Tené T Lewis; Judith H Lichtman; Chris T Longenecker; Matthew Shane Loop; Pamela L Lutsey; Seth S Martin; Kunihiro Matsushita; Andrew E Moran; Michael E Mussolino; Martin O'Flaherty; Ambarish Pandey; Amanda M Perak; Wayne D Rosamond; Gregory A Roth; Uchechukwu K A Sampson; Gary M Satou; Emily B Schroeder; Svati H Shah; Nicole L Spartano; Andrew Stokes; David L Tirschwell; Connie W Tsao; Mintu P Turakhia; Lisa B VanWagner; John T Wilkins; Sally S Wong; Salim S Virani
Journal:  Circulation       Date:  2019-03-05       Impact factor: 29.690

2.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

3.  Effects of blood-pressure-lowering treatment on outcome incidence. 12. Effects in individuals with high-normal and normal blood pressure: overview and meta-analyses of randomized trials.

Authors:  Costas Thomopoulos; Gianfranco Parati; Alberto Zanchetti
Journal:  J Hypertens       Date:  2017-11       Impact factor: 4.844

Review 4.  High-normal blood pressure and abnormal left ventricular geometric patterns: a meta-analysis.

Authors:  Cesare Cuspidi; Carla Sala; Marijana Tadic; Elisa Gherbesi; Rita Facchetti; Guido Grassi; Giuseppe Mancia
Journal:  J Hypertens       Date:  2019-07       Impact factor: 4.844

5.  Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality: A Systematic Review and Network Meta-analysis.

Authors:  Joshua D Bundy; Changwei Li; Patrick Stuchlik; Xiaoqing Bu; Tanika N Kelly; Katherine T Mills; Hua He; Jing Chen; Paul K Whelton; Jiang He
Journal:  JAMA Cardiol       Date:  2017-07-01       Impact factor: 14.676

6.  Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial.

Authors:  Giuseppe Mancia; Sverre E Kjeldsen; Dion H Zappe; Björn Holzhauer; Tsushung A Hua; Alberto Zanchetti; Stevo Julius; Michael A Weber
Journal:  Eur Heart J       Date:  2015-11-20       Impact factor: 29.983

7.  Should blood pressure ≥130/80 mm Hg be considered as a cardiovascular disease?

Authors:  Marijana Tadic; Cesare Cuspidi
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-06-19       Impact factor: 3.738

Review 8.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Paul K Whelton; Robert M Carey; Wilbert S Aronow; Donald E Casey; Karen J Collins; Cheryl Dennison Himmelfarb; Sondra M DePalma; Samuel Gidding; Kenneth A Jamerson; Daniel W Jones; Eric J MacLaughlin; Paul Muntner; Bruce Ovbiagele; Sidney C Smith; Crystal C Spencer; Randall S Stafford; Sandra J Taler; Randal J Thomas; Kim A Williams; Jeff D Williamson; Jackson T Wright
Journal:  Hypertension       Date:  2017-11-13       Impact factor: 9.897

9.  Prevalence of Hypertension, Treatment, and Blood Pressure Targets in Canada Associated With the 2017 American College of Cardiology and American Heart Association Blood Pressure Guidelines.

Authors:  Stephanie Garies; Sylvia Hao; Kerry McBrien; Tyler Williamson; Mingkai Peng; Nadia A Khan; Raj S Padwal; Hude Quan; Alexander A Leung
Journal:  JAMA Netw Open       Date:  2019-03-01

10.  Association of "Elevated Blood Pressure" and "Stage 1 Hypertension" With Cardiovascular Mortality Among an Asian Population.

Authors:  Mohammad Talaei; Naeimeh Hosseini; Angela S Koh; Jian-Min Yuan; Woon-Puay Koh
Journal:  J Am Heart Assoc       Date:  2018-04-10       Impact factor: 5.501
View more
  1 in total

1.  Should blood pressure ≥130/80 mm Hg be considered as a cardiovascular disease?

Authors:  Marijana Tadic; Cesare Cuspidi
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-06-19       Impact factor: 3.738
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.